| Differential Role of Factor XIII in Acute Myocardial Infarction and Ischemic Stroke | 
| Traub J, Weber MS, Frey A | Biomedicines | 2024 | | |
| The astrocyte-produced growth factor HB-EGF limits autoimmune CNS pathology |
| Linnerbauer M, Lößlein L, (...), Rothhammer V | Nature Immunology | 2024 | | |
| Risk factors and outcomes after interruption of sedation in subarachnoid hemorrhage (ROUTINE-SAH) -a retrospective cohort study |
| Schmidbauer M, Läufer S, Maskos A, Dimitriadis K | Frontiers in Neurology | 2024 | | |
| Polyglutamylation of microtubules drives neuronal remodeling |
| Gavoci A, Zhiti A, (...), Brill MS | bioRxiv | 2024 | | |
| Gut–Brain Interactions and Their Impact on Astrocytes in the Context of Multiple Sclerosis and Beyond |
| Zißler J, Rothhammer V, Linnerbauer M | Cells | 2024 | | |
| Shared inflammatory glial cell signature after stab wound injury, revealed by spatial, temporal, and cell-type-specific profiling of the murine cerebral cortex |
| Koupourtidou C, Schwarz V, (...), Ninkovic J | Nature Communications | 2024 | | |
| Fluorogenic Chemical Probes for Wash-free Imaging of Cell Membrane Damage in Ferroptosis, Necrosis, and Axon Injury | | Mauker P, Beckmann D, (...), Thorn-Seshold O | Journal of the American Chemical Society | 2024 | | |
| Synaptogenic gene therapy with FGF22 improves circuit plasticity and functional recovery following spinal cord injury |
| Aljović A, Jacobi A, (...), Bareyre FM | EMBO Molecular Medicine | 2023 | | |
| Targeting B Cells and Microglia in Multiple Sclerosis With Bruton Tyrosine Kinase Inhibitors | | Dybowski S, Torke S, Weber MS | JAMA Neurology | 2023 | | |
| Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency |
| Schlotawa L, Tyka K, (...), Gärtner J | EMBO Molecular Medicine | 2023 | | |
10.3390/biomedicines12030497
38409259
